Scaling Down for Big Impact: Streamlined High-throughput Recombinant Adeno-associated Virus Production.

IF 1.2 4区 综合性期刊 Q3 MULTIDISCIPLINARY SCIENCES
Philip Ohland, Miriam L Ferreiro, Jatina Schumacher, Linda E Franken, Catherine McKenzie, Thomas Steininger, Philippe Ringler, Matthias E Lauer, Denis Phichith, Julia Fakhiri
{"title":"Scaling Down for Big Impact: Streamlined High-throughput Recombinant Adeno-associated Virus Production.","authors":"Philip Ohland, Miriam L Ferreiro, Jatina Schumacher, Linda E Franken, Catherine McKenzie, Thomas Steininger, Philippe Ringler, Matthias E Lauer, Denis Phichith, Julia Fakhiri","doi":"10.3791/68646","DOIUrl":null,"url":null,"abstract":"<p><p>In recent years, recombinant adeno-associated viral (rAAV) vectors have emerged as a leading platform for gene therapy applications. However, the cumbersome production and purification processes remain significant bottlenecks in drug development. High-throughput, small-scale rAAV production without labor-intensive and time-consuming purification procedures offers a valuable alternative strategy to accelerate preclinical research and early-stage therapeutic screening. This approach enables the rapid generation of diverse rAAV variants or therapeutic constructs with sufficient quality for initial in vitro and in vivo evaluation. This protocol introduces two methods distinguished by cell type and production scale: microscale and miniscale rAAV production. Microscale production is carried out in a 6-well format using adherent human embryonic kidney (HEK) 293T cells (micro-6-well), while miniscale production utilizes suspension cells in 24-well plates (mini-HT24). Vectors generated through these methods undergo downstream analyses to optimize cell culturing conditions and/or are used to assess the biological activity of transgenes. Key analytical readouts include vector genome titration (vg/mL), capsid titer determination (vp/mL), western blot analysis, and cell transduction assays. Additionally, vectors produced at the miniscale and semi-purified using affinity resins are compared with midiscale preparations purified via cesium chloride density gradients. The streamlined methods described here demonstrate significant potential for refining cell culture parameters, identifying lead candidates during screenings (i.e., optimized transgene cassettes or superior AAV capsids), and enhancing transgene expression. Collectively, the presented workflows support the establishment of a robust and efficient platform for iterative development in the gene therapy pipeline that can be readily implemented in any research lab.</p>","PeriodicalId":48787,"journal":{"name":"Jove-Journal of Visualized Experiments","volume":" 223","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jove-Journal of Visualized Experiments","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.3791/68646","RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

In recent years, recombinant adeno-associated viral (rAAV) vectors have emerged as a leading platform for gene therapy applications. However, the cumbersome production and purification processes remain significant bottlenecks in drug development. High-throughput, small-scale rAAV production without labor-intensive and time-consuming purification procedures offers a valuable alternative strategy to accelerate preclinical research and early-stage therapeutic screening. This approach enables the rapid generation of diverse rAAV variants or therapeutic constructs with sufficient quality for initial in vitro and in vivo evaluation. This protocol introduces two methods distinguished by cell type and production scale: microscale and miniscale rAAV production. Microscale production is carried out in a 6-well format using adherent human embryonic kidney (HEK) 293T cells (micro-6-well), while miniscale production utilizes suspension cells in 24-well plates (mini-HT24). Vectors generated through these methods undergo downstream analyses to optimize cell culturing conditions and/or are used to assess the biological activity of transgenes. Key analytical readouts include vector genome titration (vg/mL), capsid titer determination (vp/mL), western blot analysis, and cell transduction assays. Additionally, vectors produced at the miniscale and semi-purified using affinity resins are compared with midiscale preparations purified via cesium chloride density gradients. The streamlined methods described here demonstrate significant potential for refining cell culture parameters, identifying lead candidates during screenings (i.e., optimized transgene cassettes or superior AAV capsids), and enhancing transgene expression. Collectively, the presented workflows support the establishment of a robust and efficient platform for iterative development in the gene therapy pipeline that can be readily implemented in any research lab.

缩小规模以产生重大影响:流线型高通量重组腺相关病毒生产。
近年来,重组腺相关病毒(rAAV)载体已成为基因治疗应用的主要平台。然而,繁琐的生产和纯化过程仍然是药物开发的重大瓶颈。高通量、小规模的rAAV生产,无需劳动密集型和耗时的纯化程序,为加快临床前研究和早期治疗筛选提供了一种有价值的替代策略。这种方法能够快速生成不同的rAAV变体或具有足够质量的治疗结构,用于初始的体外和体内评估。该协议介绍了两种不同细胞类型和生产规模的方法:微型和微型rAAV生产。小规模生产采用贴壁人胚胎肾(HEK) 293T细胞(micro-6孔),以6孔形式进行,而小规模生产采用悬浮细胞在24孔板(mini-HT24)中进行。通过这些方法产生的载体进行下游分析以优化细胞培养条件和/或用于评估转基因的生物活性。主要分析读数包括载体基因组滴定(vg/mL),衣壳滴度测定(vp/mL), western blot分析和细胞转导测定。此外,使用亲和树脂在小规模和半纯化条件下生产的载体与通过氯化铯密度梯度纯化的中型制剂进行了比较。本文描述的简化方法在优化细胞培养参数,在筛选过程中确定主要候选物(即优化的转基因盒或优质的AAV衣壳)以及增强转基因表达方面具有重要潜力。总的来说,所提出的工作流程支持在基因治疗管道中建立一个健壮且有效的迭代开发平台,该平台可以在任何研究实验室中轻松实现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Jove-Journal of Visualized Experiments
Jove-Journal of Visualized Experiments MULTIDISCIPLINARY SCIENCES-
CiteScore
2.10
自引率
0.00%
发文量
992
期刊介绍: JoVE, the Journal of Visualized Experiments, is the world''s first peer reviewed scientific video journal. Established in 2006, JoVE is devoted to publishing scientific research in a visual format to help researchers overcome two of the biggest challenges facing the scientific research community today; poor reproducibility and the time and labor intensive nature of learning new experimental techniques.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信